Compound Detail
CHEMBL419792
SUMANIROLE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL419792 |
| Name | SUMANIROLE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | RKZSNTNMEFVBDT-MRVPVSSYSA-N |
4
Targets
25
Activities
2
Assay Types
0
PK Parameters
20
Publications
4
Known Names
1
Indications
1
Mechanisms
Molecular Properties
203.2
MW (Da)
0.47
ALogP
3
HBA
2
HBD
49.8
PSA (Ų)
0.71
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine D2 receptor agonist | AGONIST | D(2) dopamine receptor | ✓ | ✓ |
Indications
Parkinson Disease
Activity Summary
Ki 13 meas. best 8.05
EC50 12 meas. best 8.34
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL217 | EC50 | 8.34 | 7.0888 | 4.6 | 8 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.05 | 6.6367 | 9.0 | 6 |
| D(2) dopamine receptor CHEMBL339 | EC50 | 7.97 | 7.715 | 10.8 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 7.14 | 7.14 | 73.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | EC50 | 6.73 | 6.45 | 186.0 | 2 |
| D(3) dopamine receptor CHEMBL234 | Ki | 6.26 | 5.7733 | 546.0 | 6 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28300398 | 10.1021/acs.jmedchem.6b01875 | D(2) dopamine receptor | 9 |
| 27035329 | 10.1021/acs.jmedchem.5b01612 | D(2) dopamine receptor | 7 |
| 27035329 | 10.1021/acs.jmedchem.5b01612 | D(3) dopamine receptor | 6 |
| 15239663 | 10.1021/jm030505a | D(2) dopamine receptor | 6 |
| 9057850 | 10.1021/jm960360q | Mus musculus | 4 |
| 27035329 | 10.1021/acs.jmedchem.5b01612 | Unchecked | 4 |
| 15239663 | 10.1021/jm030505a | D(4) dopamine receptor | 3 |
| 9057850 | 10.1021/jm960360q | ADMET | 3 |
| 34699207 | 10.1021/acs.jmedchem.1c01433 | D(3) dopamine receptor | 2 |
| 34699207 | 10.1021/acs.jmedchem.1c01433 | D(2) dopamine receptor | 2 |
| 34699207 | 10.1021/acs.jmedchem.1c01433 | Unchecked | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 9057850 | 10.1021/jm960360q | D(4) dopamine receptor | 1 |
| 9057850 | 10.1021/jm960360q | 5-hydroxytryptamine receptor 2A | 1 |
| 9057850 | 10.1021/jm960360q | Opioid receptors; mu/kappa/delta | 1 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
| 9057850 | 10.1021/jm960360q | GABA-A receptor; anion channel | 1 |
| 9057850 | 10.1021/jm960360q | Adrenergic receptor alpha-2 | 1 |
| 9057850 | 10.1021/jm960360q | Adrenergic receptor alpha-1 | 1 |
Data from ChEMBL 36 via Core Engine